neuraminidase inhibitor

These drugs are inhibitors of neuraminidase, a glycoprotein on the surface of the influenza virus. Inhibition of neuraminidase activity decreases the release of virus from infected cells, increases the formation of viral aggregates, and decreases the spread of the virus through the body. If taken within 30 hours…

…of antiviral drugs known as neuraminidase inhibitors. Oseltamivir is marketed as Tamiflu by the U.S.-based pharmaceutical company Hoffman–La Roche, Inc.

…newer category of drugs, the neuraminidase inhibitors, which includes oseltamivir (Tamiflu) and zanamivir (Relenza), was introduced in the late 1990s; these drugs inhibit both the influenza A and B viruses. Other than this, the standard treatment remains bed rest, ingestion of fluids, and the use of analgesics to control

Drugs called neuraminidase inhibitors, which include oseltamivir (Tamiflu) and zanamivir (Relenza), inhibit the release of influenza A and B viruses from host cells. This inhibition stops the process of viral replication. Neuraminidase inhibitors are commonly used in both the prevention and the treatment of influenza.